News
The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...
A nasal spray called FluMist has been approved by the U.S. Food and Drug Administration as an alternative to the traditional injection of the flu vaccine. Krista McNally Sep 24, 2024, 9:30 PM ...
FDA accepts Milestone's response on Cardamyst nasal spray, sets new PDUFA date; company raises $52.5 million to support ...
Children who have an allergy that could cause anaphylaxis symptoms such throat swelling and other severe reactions have long had to carry an epinephrine injectable pen with them or have one stored ...
9mon
India Today on MSNUS approves first nasal spray flu vaccine that can be self-administeredFluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a ...
New PDUFA Action Date of December 13, 2025 $75 Million Royalty Purchase Agreement Payment from RTW Extended Through 2025 MONTREAL and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone® ...
Today’s health headlines: ketamine nasal sprays offer a new option for people with treatment-resistant depression. Plus, how ...
Half of the subjects were given the esketamine nasal spray in one of two strengths, along with a new oral antidepressant that varied from person to person. The other group was given a new oral ...
The Food and Drug Administration approved the first needle-free alternative to the EpiPen, a single-use epinephrine nasal spray for emergency treatment of allergic reactions, including anaphylaxis.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results